Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Teva Pharmaceutical Industries Limited (IL:TEVA)

:TEVA

TEVA

Teva

RESEARCH TOOLSreports

Teva (TEVA) Stock News & Sentiment

Compare

49 Followers

Teva Buy Rating Reinforced by Strong TL1a Phase 2 Data and $3 Billion Duvakitug Peak Sales Outlook

Premium

Ratings

Teva Buy Rating Reinforced by Strong TL1a Phase 2 Data and $3 Billion Duvakitug Peak Sales Outlook

1M ago

TEVA

Premium

Ratings

Teva Pharmaceutical: Strategic Focus and Financial Stability Drive Buy Rating

6M ago

TEVA

Premium

Ratings

Teva Pharmaceutical’s Favorable Position in IRA Negotiations Drives Buy Rating

8M ago

TEVA

Premium

Ratings

Teva Pharmaceutical’s Austedo Poised for Growth: Analyst Recommends Buy Rating

8M ago

TEVA

Premium

Ratings

Teva Pharmaceutical’s Promising Growth Prospects and Strategic Initiatives Drive Buy Rating

9M ago

TEVA

Premium

Ratings

Teva Pharmaceutical’s Strategic Edge and Growth Potential: Analyst Recommends Buy Rating

9M ago

TEVA

Premium

Ratings

Teva Pharmaceutical’s Promising Long-term Outlook: Buy Rating Backed by Strategic Initiatives and FCF Growth Potential

10M ago

TEVA

More IL:TEVA News >

TEVA News on the Web

2026-03-10

FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment

CNBC

Neutral

2026-03-05

J.P. Morgan Sticks to Their Buy Rating for Teva Pharmaceutical (TEVA)

TipRanks News

Neutral

2026-03-03

Teva, Blackstone announce $400M strategic funding agreement for duvakitug

TipRanks News

Bullish

2026-02-24

Unusually active option classes on open February 24th

TipRanks News

Neutral

2026-02-20

Corcept Therapeutics price target lowered to $67 from $105 at H.C. Wainwright

TipRanks News

Neutral

2026-02-19

Midday Fly By: Walmart reports Q4 beat, eBay to acquire Depop from Etsy

TipRanks News

Neutral

2026-02-19

Corcept Therapeutics down 18% after appeals court ruling in Teva fight

TipRanks News

Neutral

2026-02-19

Truist Financial Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)

TipRanks News

Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IL:TEVA’s Media Buzz Sentiment?

Currently, no data Available

What is IL:TEVA’s weekly average amount of articles?

Currently, no data Available

What is IL:TEVA’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

KHTRFKnight Therapeutics

HYPRHyperfine

KMTSKestra Medical Technologies Ltd.

OVIDOvid Therapeutics

PYPDPolyPid

Showing the stocks with the most bullish news sentiment over the past week